17β-estradiol promotes angiogenesis through non-genomic activation of Smad1 signaling in endometriosis
article
OA: closed
CC0
⤵ 5 in-corpus citations
AI-generated summary
17β-estradiol promotes angiogenesis in endometriosis via non-genomic activation of Smad1 signaling, contributing to the disease's development.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
17β-estradiol (E2) plays a key role in endometriosis through regulation of angiogenesis. Smad1 has been reported to be up-regulated in patients with endometriosis. However, the role of Smad1 in E2-mediated angiogenesis during the development of endometriosis remains to be determined. This study aimed to explore the role of Smad1 in E2-mediated angiogenesis during endometriosis and its underlying mechanisms. Immunofluorescence staining and Western blotting were performed to examine the expression of p-Smad1 in ectopic and control endometrium. Western blotting was used to examine activation of Smad1 signaling in NMECs, EMECs and HUVECs. Tube formation assay was performed to examine the effect of E2 on angiogenesis. Cell proliferation and migration was determined using in real-time by xCELLigence RTCA DP instrument. We found that the expression of p-Smad1 was significantly up-regulated in ectopic endometrium and ectopic intima microvascular endothelial cells. E2 non-genomically stimulated phosphorylation of Smad1 in HUVECs. c-Src and p44/42 MAPK(ERK1/2) signaling pathways are required for E2's induction on Smad1 phosphorylation. Moreover, caveolae is involved in E2-induced Smad1 phosphorylation in vascular endothelial cells. E2 promoted tube formation of vascular endothelial cells through c-Src/ERK1/2/Smad1 signaling pathway. Knockdown of Smad1 expression attenuated E2-induced proliferation and migration of HUVECs. In conclusion, E2 promotes proliferation, migration and tube formation of HUVECs through c-Src/ERK1/2/Smad1 signaling pathway. Our data shed new lights on the mechanisms through which E2 contributes to endometriosis, and may provide novel strategies to treat endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (41)
- Angiogenesis and Endometriosis via openalex
- Anti-angiogenic treatment of endometriosis via anti-VEGFA siRNA delivery by means of peptide-based carrier in a rat subcutaneous model via openalex
- Dual inhibition of ERK1/2 and AKT pathways is required to suppress the growth and survival of endometriotic cells and lesions via openalex
- Endometrial and Endometriotic Concentrations of Estrone and Estradiol Are Determined by Local Metabolism Rather than Circulating Levels via openalex
- Endometriosis via openalex
- Endometriosis, Angiogenesis and Tissue Factor via openalex
- Estrogen-decreased hsa_circ_0001649 promotes stromal cell invasion in endometriosis via openalex
- Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis via openalex
- <i>ESR1</i>rs9340799 Is Associated with Endometriosis-Related Infertility and<i>In Vitro</i>Fertilization Failure via openalex
- Molecular mechanisms underlying endometriosis pathogenesis revealed by bioinformatics analysis of microarray data via openalex
- Oestrogen induces epithelial‐mesenchymal transition in endometriosis via circ_0004712/miR‐148a‐3p sponge function via openalex
- Potential role of aromatase inhibitors in the treatment of endometriosis via openalex
- VEGF Receptor 1-Expressing Macrophages Recruited from Bone Marrow Enhances Angiogenesis in Endometrial Tissues via openalex
- W2123480209 via openalex
- W2124375064 via openalex
- W2129503523 via openalex
- W2140246703 via openalex
- W2141369673 via openalex
- W2144534157 via openalex
- W2530229975 via openalex
- W2583968028 via openalex
- W2617005810 via openalex
- W2791193457 via openalex
- W2802402911 via openalex
- W2969259417 via openalex
- W2969877657 via openalex
- W2999183094 via openalex
- W3012616341 via openalex
- W6684182588 via openalex
- W1971951473 via openalex
- W1985959551 via openalex
- W1986965597 via openalex
- W2001835897 via openalex
- W2017451770 via openalex
- W2023581428 via openalex
- W2047270721 via openalex
- W2051109788 via openalex
- W2087892362 via openalex
- W2089633892 via openalex
- W2106303836 via openalex
- W2110555613 via openalex
Cited by (7)
- Endometriosis-associated Pain: Mechanism, Neuroimmune Signature, and Translational Precision Strategies 2026
- Estetrol potentiates progesterone-driven growth restraint while blunting pro-angiogenic activation in murine endometriosis lesions 2026
- Large Peritoneal Macrophages Promote the Resolution of Inflammation in Injured Endometrium 2025
- Neuroendocrine-Immune Axis in Endometriosis: A Review on How the Nervous System Goes Beyond Pain Perception 2025
- The Scribble-Rac1 signaling axis drives epithelial cell motility and contributes to diffuse adenomyosis pathogenesis 2025
- An Estrogen-NK Cells Regulatory Axis in Endometriosis, Related Infertility, and Miscarriage 2024
- Research advances in endometriosis-related signaling pathways: A review 2023
Source provenance
- europepmc
- last seen: 2026-07-30T06:25:42.655704+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:08.918168+00:00
License: CC0
· commercial use OK